What is the purpose of the study?
This study will involve MRI and PET imaging that will measure brain inflammation as well as the density of the connections between brain cells in Obsessive Compulsive Disorder. Participants CANNOT be currently taking antidepressant medication, smoking or using any street drugs, pregnant or breastfeeding. Compensation will be provided.
Who is needed?
- Individuals with Obsessive Compulsive Disorder, Depression
- Individuals without a mental health or addiction problem
Age range: 18 - 80
Gender: All
Ethnicity: All
What does the study involve?
- Number of contacts: 1 phone call, 4 sessions at CAMH
- Time period: 8 - 12 weeks
- Length of contacts: 20 min. phone call, 4-hour session, 6-hour session, 2-hour session, 4-hour session
- Treatment offered: No
Study Location(s):
250 College St., Research Imaging Centre
Investigator(s): Dr. Jeffrey Meyer
Contact Information:
- Phone: 416-535-8501 ext.32562
- E-mail: ocd.imagingstudy@camh.ca
Study End Date: 31 December 2025
REB number: 023/2022
Full Study Title: Microglial Activation in Major Depressive Disorder: Relationship to Comorbidity and Loss of Synaptic Density
PLEASE NOTE:
- Research staff cannot give medical advice over the phone.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.